Plocamium Holdings

CVS Plans to Split Into Two Public Companies, Keeping Aetna and Caremark Together

Listen to this article
0:00 / --:--
✦ Takeaways by PlocamiumAI
  • CVS Health plans two public companies: CVS Health, holding Aetna and Caremark, and CVS Pharmacy, holding its 9,000 retail pharmacies. Completion is expected in the first half of 2028.
  • CEO David Joyner says regulatory pressure is not the reason for the split, and that CVS will keep the link between Aetna and Caremark and between Aetna and its care delivery arm.
  • The announcement came with third-quarter profit of $2.2 billion on revenue of $108.4 billion and a raised 2026 outlook.

CVS Health plans to split into two companies, one housing its insurer Aetna and its pharmacy benefit manager Caremark, and the other holding its 9,000 retail pharmacies. Executives confirmed the plan on Nov. 4 after media reports on Nov. 3. CVS expects to complete the split in the first half of 2028. [1]

CEO David Joyner told investors on a call that the separation should make each team quicker and better able to compete. A company press release said each will have its own stock listing, and existing shareholders will hold stock in both. [1]

What Goes Where

The company holding Aetna and Caremark will keep the CVS Health name under Joyner, along with senior care provider Oak Street Health, home health firm Signify Health and the specialty drug unit. [1]

The other, CVS Pharmacy, gets the stores, the mail order and walk-in clinic businesses and Health100 technology services. Prem Shah, now CVS' group president, will run it. [1]

CompanyLeaderMain businesses
CVS HealthDavid JoynerAetna, Caremark, Oak Street Health, Signify Health, specialty drugs
CVS PharmacyPrem ShahRetail stores, mail order pharmacy, walk-in clinics, Health100 technology services

The Reasoning, and the Pressure Around It

The plan reverses a two-decade run of acquisitions that included Caremark in 2007, Aetna in 2018 and medical groups such as Oak Street Health and Signify Health. Arielle Trzcinski, a principal analyst at Forrester, said the split undoes a core part of the logic of those deals, and that CVS is "effectively acknowledging that bigger isn't always better." [1]

Regulatory and legislative pressure is building around the model. State laws in Arkansas and Tennessee, which CVS is challenging, would bar one parent from owning both pharmacies and PBMs, and a bipartisan group in Congress has proposed the same at the federal level. Joyner, however, said regulatory pressure is not the reason for the split. He described it as the next step in CVS' evolution, one that creates two organizations able to tailor strategy and investment to their own needs. [1]

Leerink analyst Michael Cherny offered a different reading, saying the rationale could be to avoid what he called relentless state legislative scrutiny of the company's vertical integration. He also said the breakup "feels like a complete shock." J.P. Morgan analyst Lisa Gill wrote that she sees some logic to the split. [1]

What Stays Connected

Joyner said the ties CVS most wants to keep are those linking Aetna to Caremark and Aetna to its care delivery arm. He said the retail pharmacy has always operated behind a firewall, so carving it out will not remove valuable overlaps, and that any joint products and services CVS wants to keep will be retained through commercial agreements between the two companies. [1]

On its own, CVS Pharmacy will face the pressures that have pushed some other pharmacy operators into bankruptcy or private ownership. The report said CVS has lifted pharmacy results in recent years with fewer stores, more prescriptions and reimbursement tied more closely to what drugs cost to buy. Cherny noted that the pharmacies have stabilized for the first time in years. [1]

The Quarter Behind the News

CVS reported third-quarter profit of $2.2 billion on revenue of $108.4 billion, against a loss of $4 billion on revenue of $102.9 billion a year earlier, and raised its 2026 outlook. Aetna did better than expected as its Medicare Advantage margins kept recovering, and the pharmacy division gained from drug demand and the Rite Aid assets CVS bought. Joyner described the split as an action taken "from a position of strength." The company had earlier cut $2 billion in costs, closed stores, overhauled its executive team and shuttered plans after Aetna was hit by higher-than-expected medical spending. [1]

The Plocamium View

The reported facts are mixed on whether integration has failed. Healthcare Dive calls the split an indictment of the strategy, yet CVS is keeping the pieces it says it values most, Aetna with Caremark and Aetna with care delivery, and separating the retail stores, which it says already ran behind a firewall. CVS presents this as a narrowing of the integrated model rather than an abandonment of it.

The timing also matters. By Plocamium's arithmetic, the move from a $4 billion loss to a $2.2 billion profit is a $6.2 billion swing, revenue rose about 5.3% ($108.4 billion less $102.9 billion, divided by $102.9 billion), and profit was about 2.0% of revenue ($2.2 billion divided by $108.4 billion). The split is being announced after the recovery, not during a crisis.

Three things are worth watching. First, how the commercial agreements between the two companies are written, since they are meant to carry the joint products CVS wants to keep. Second, how CVS Pharmacy performs as a standalone business under Shah, given the pressures the report describes for pharmacy operators. Third, whether the state and federal bills on common ownership of pharmacies and PBMs move forward, because Joyner and Leerink's Michael Cherny disagree about how much they shaped this decision. This is analysis of the reported facts, not a recommendation on either future stock.

Correction, Nov. 5, 2026: An earlier version of this article said CVS would separate its retail pharmacy operations from its health insurance business and reverse its 2018 acquisition of Aetna. In fact, one company will hold both Aetna and Caremark, and CVS says it will preserve the connection between them and between Aetna and its care delivery arm. The earlier version also attributed the split to a conglomerate discount, Federal Trade Commission scrutiny and activist pressure; the reporting supports none of these, and Joyner said regulatory pressure is not the reason. It said financial terms and details were not disclosed, when the company said both companies will be publicly traded, shareholders will own both, and completion is expected in the first half of 2028. It described CVS as having struggled and underperformed, when the company reported a third-quarter profit and raised its outlook. It also said the insurer could contract with all pharmacy networks, and included comparisons and market predictions we could not support. They have been removed or replaced.

Sources

[1] Healthcare Dive. "CVS to split into two companies in stunning strategic about-face." Rebecca Pifer Parduhn, Nov. 4, 2026. https://www.healthcaredive.com/news/cvs-split-two-companies-strategic-about-face/873660/

This report is for informational purposes only and does not constitute investment advice or an offer to buy or sell any security. Content is based on publicly available sources believed reliable but not guaranteed. Opinions and forward-looking statements are subject to change; past performance is not indicative of future results. Plocamium Holdings and its affiliates may hold positions in securities discussed herein. Readers should conduct independent due diligence and consult qualified advisors before making investment decisions.

© 2026 Plocamium Holdings. All rights reserved.

Contact Us